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a b s t r a c t
Respiratory syncytial virus is a major cause of bronchiolitis in infants and pneumonia virus of mice
(PVM) causes similar disease in mice. The impact of PVM infection in BALB/c and C57BL/6 neonates, and
upon re-infection as elderly mice, was compared. As previously shown for adult mice, PVM caused more
disease in BALB/c than in C57BL/6 neonates. After PVM-15 infection BALB/c neonates showed higher
production of inﬂammatory mediators, more inﬂux of plasmacytoid dendritic cells and higher IFN-α
expression, and more IgA in the lungs than C57BL/6 neonates. After re-infection as elderly, BALB/c mice
developed virus neutralizing antibodies in serum and lung, and were protected from clinical disease,
whereas C57BL/6 mice did not develop an anamnestic response and were not protected. These results
suggest that an effective local innate response, as well as priming of mucosal adaptive responses in
neonates after PVM-15 infection is correlated to decreased susceptibility and protection upon re-
infection.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Human respiratory syncytial virus (RSV) is the major cause of
hospitalization due to lung infection in infants and young children
(Tregoning and Schwarze, 2010). Young infants between six weeks
and six months of age are most vulnerable to severe RSV infection,
and by two years of age almost all children have been infected at
least once with RSV (Glezen et al., 1986; Ruckwardt et al., 2011).
RSV infection in infants does not result in protective immunity,
and as a result re-infections are common throughout life (Cormier
et al., 2010). Severe RSV infection in childhood is associated with
development of wheezing and asthma later in life (Openshaw
et al., 2003; Sigurs et al., 2005; You et al., 2006). An efﬁcient RSV
vaccine or a therapeutic drug against RSV is much needed for
infants; however, our limited understanding of the neonatal
immune system is a major hurdle. Mice and cotton rats are
commonly used animal models to study RSV pathogenesis, and
they have signiﬁcantly contributed to our improved insight into
the disease; however, animal studies with a human pathogen may
not truly reﬂect the disease caused in humans (Cormier et al.,
2010; Openshaw, 2013). Furthermore, adult animal models, which
have been widely used to understand RSV pathogenesis, do not
truly imitate human RSV disease in infants. Therefore, an age-
relevant neonatal mouse model is an indispensable tool in under-
standing the outcome of RSV infection and re-infection (Cormier
et al., 2010).
The neonatal immune system is considered functionally imma-
ture and it is interpreted as TH2/TH17-polarized, which is possibly
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a functional adaptation to prevent hyperinﬂammation and
immune responses to maternal antigen (Cuenca et al., 2013). In
past decades, several neonatal mouse models that mimic RSV
pathogenesis of human infants have been developed (Culley et al.,
2002; Dakhama et al., 2005; Empey et al., 2012; Ruckwardt et al.,
2011; You et al., 2006). These studies have demonstrated that RSV
elicits a limited TH1-type response in BALB/c neonates, and that
BALB/c mice primed as neonates had a skewed TH2-biased
response after re-infection with RSV at 4 weeks of age (Cormier
et al., 2014a; You et al., 2013). In human infants, a correlation
between mild RSV infection and expression of IFN-related genes,
without suppression of B cell genes, has been reported (Mejias
et al., 2013). The severity of neonatal RSV infection has also been
shown to be associated with host genetics, and the MHC haplotype
appears to be a major contributor to this response (Tregoning
et al., 2010).
To better understand the systemic and local immune response
to RSV infection and re-infection, an age-relevant species-speciﬁc
animal model is of vital importance (Bem et al., 2011). Pneumonia
virus of mice (PVM) can be considered a natural disease model for
RSV infection. PVM causes an infection in all inbred strains of mice,
but the inﬂammatory responses to PVM vary between mouse
strains (Anh et al., 2006; Dyer et al., 2012). We have previously
shown that the difference in susceptibility of BALB/c and C57BL/6
mice might be related to the ability of the C57BL/6 mice to better
control both the viral replication and the immune response
elicited by PVM (Watkiss et al., 2013). However, while RSV causes
the most severe disease in newborn infants, there are relatively
few studies on PVM infection in neonates in comparison to PVM
studies in adult mice. In BALB/c neonates, recognition of PVMJ336
by pDCs has been shown to be TLR7-mediated and critical for
limiting PVM load (Davidson et al., 2011). In another study in
C57BL/6 neonates there was diminished pro-inﬂammatory leuko-
cyte inﬂux and chemokine production in lungs in response to
PVMJ336 (Bonville et al., 2010).
In the present study, as a part of our ongoing interest in exploring
RSV disease pathogenesis using a natural rodent pathogen, we
examined how BALB/c and C57BL/6 mice respond to PVM infection
as neonates, as well as after re-infection as elderly mice. These age
groups were chosen as they are most susceptible to severe RSV
infection. A comprehensive analysis of primary PVM-15 infection in
neonatal BALB/c and C57BL/6 mice, as well as secondary infection in
elderly mice primed as neonates was performed. The results indicate
that development of local innate immune responses, as well as
mucosal adaptive responses in BALB/c mice play a major role in
protection from re-infection later in life.
Results
Neonatal BALB/c mice experience more severe clinical disease and
inﬂammatory responses than C57BL/6 neonates
To determine the strain effect on the response to PMV infection
in neonates, seven day-old BALB/c and C57BL/6 mice were infected
with 300 pfu PVM-15 and weighed daily from day 0 to 7 post-
infection. The PVM-15 infected newborn BALB/c mice started to
show reduced weight gain on day 1 post-infection and diverged
signiﬁcantly from mock-infected mice from day 4 onwards
(Fig. 1A). Interestingly, PVM-15 infected C57BL/6 pups continued
to gain weight up to day 5 with a sudden signiﬁcant weight loss on
days 6 and 7 (Fig. 1B). Virus titers were measured on days 3, 5 and
7 in the PVM-infected BALB/c and C57BL/6 pups. This showed that
the virus titre was signiﬁcantly elevated on day 7 in BALB/c pups
when compared with C57BL/6 pups (Fig. 1C).
Inﬂammatory responses contribute to disease symptoms
caused by PVM, so we determined which inﬂammatory mediators
are associated with PVM-15 infection in BALB/c and C57BL/6
neonates. Cytokine proﬁles in the lungs were measured on day 7
post-infection. PVM-15 infection led to enhanced production of IL-
12, TNF-α and IFN-γ in BALB/c neonates when compared to non-
infected BALB/c neonates and infected C57BL/6 neonates (Fig. 2A).
However, there was no signiﬁcant increase in the production of
these inﬂammatory mediators in C57BL/6 neonates after PVM-15
infection when compared to mock-infected animals (Fig. 2A).
BALB/c neonates also produced increased amounts of IL-13, while
they tended to produce more IL-5 after PVM infection (Fig. 2B).
Although C57BL/6 neonates showed the same trend, the difference
was not statistically signiﬁcant (Fig. 2B). Furthermore, infected
neonatal BALB/c mice had substantially increased levels of CCL2
(MCP-1/JE), CCL3 (MIP-1α) and CXCL1 (KC-GRO) compared to mo-
ck-infected age-matched controls and PVM-15 infected C57BL/6
Fig. 1. Weight change and virus replication in lungs of neonatal BALB/c and C57BL/6
mice after primary infection. Seven day-old BALB/c and C57BL/6 neonates were
infected with 300 pfu PVM-15 or received medium (Mock). (A and B) Neonates were
weighed daily from day 0 up to day 7 p.i as litters. Analysis of weight loss was
performed as a measure of disease severity, and change is expressed as % of original
weight. Data represent means 7 SEM. (C) Viral burden in lungs after primary
infection as neonates. Virus titers are expressed as (log 10) pfu/g. Data are representa-
tive of a combination of three independent experiments with 6–8 pups per group.
Signiﬁcance of differences is shown as: nPo0.05; nnPo0.01; nnnPo 0.001.
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mice (Fig. 2C). However, C57BL/6 neonates secreted more CXCL2
(MIP-2) in comparison to BALB/c neonates (Fig. 2C).
As pDCs are important players in initiating host immune responses
to PVM infection, we examined the recruitment of pDCs into the lungs
of neonatal BALB/c and C57BL/6 mice after PVM infection by ﬂow
cytometry. Fig. 3A shows the gating strategy to identify pDCs. Neonatal
BALB/c mice showed a signiﬁcant inﬂux of pDCs into their lungs on
day 5 after PVM-15 inoculation; however this was not observed in
C57BL/6 neonates (Fig. 3B). In addition, IFN-α, but not IFN-β, was
signiﬁcantly up-regulated in BALB/c neonates after primary infection,
signiﬁcantly more than in C57BL/6 neonates (Fig. 3C and D).
Antibody responses in neonatal BALB/c and C57BL/6 mice after PVM
infection.
To determine whether the mouse strain inﬂuences the magni-
tude or quality of the antibody responses to PVM infection,
neonatal BALB/c and C57BL/6 mice were infected with PVM-15,
and antibody titers were determined in both serum and lungs.
Serum IgG titers were maximal on day 28 post-infection and then
gradually declined over time (data not shown). Serum IgG titers
were higher in C57BL/6 neonates than in BALB/c neonates as
shown in Fig. 4A for day 28. There was no signiﬁcant difference in
lung IgG levels in neonates after primary infection, while BALB/c
mice had higher IgA titers than C57BL/6 mice (Fig. 4A). In neonatal
BALB/c mice the PVM-speciﬁc antibody type after primary infec-
tion was predominantly IgG2a indicating a Th1-biased response,
while neonatal primary infection in C57BL/6 mice leads to a
balanced IgG1/IgG2c response (Fig. 4B). There was no signiﬁcant
difference in lung and serum neutralizing antibody titers between
the mouse strains after infection as neonates (Fig. 4C and D).
The severity of re-infection of elderly mice primed as neonates with
PVM is dependent on the mouse strain.
To determine whether priming with PVM ameliorates the
severity of disease upon re-infection, seven day-old BALB/c and
C57BL/6 mice were infected with 300 pfu PVM-15 and re-infected
(RI) with 3000 pfu PVM-15 at 18 months of age. To determine how
the same amount of virus impacts primary infection and re-
infection in two different strains of mice, which represents to an
extent the variation within a human population, and in agreement
with reports by others who compared the susceptibility of several
mouse strains to PVM (Anh et al., 2006) or RSV (Tregoning et al.,
2010), the dose was kept constant between the two mouse strains.
To assess the severity of disease mice were weighed up to day 6 post-
infection. Elderly BALB/c mice with a primary PVM infection exhibited
signiﬁcant weight loss compared to re-infected mice in which no
reduction in weight was observed (Fig. 5A). In contrast, 18 month-old
C57BL/6 mice displayed apparently little, but signiﬁcant weight loss
on days 2, 4 and 6 after re-infection regardless of whether they were
primed or not (Fig. 5B). While the amount of virus replication was
signiﬁcantly lower in re-infected BALB/c mice when compared to age-
matched BALB/c mice after primary infection, no difference in virus
recovery was observed in elderly C57BL/6 mice after primary infec-
tion and re-infection (Fig. 5C). Furthermore, after re-infection of
neonatally primed BALB/c and C57BL/6 mice the amount of virus
recovered from C57BL/6 mice when compared to BALB/c mice on day
6 was signiﬁcantly higher (Fig. 5C).
Diminished production of pro-inﬂammatory mediators after primary
PVM infection and enhanced secretion after re-infection in C57BL/6
mice in comparison to BALB/c mice.
Subsequently, we determined which inﬂammatory mediators
are associated with PVM-15 infection in BALB/c and C57BL/6 mice
after primary infection or re-infection as elderly. Cytokine proﬁles
in the lungs were measured on day 6 post-infection. Eighteen
month-old BALB/c mice infected for the ﬁrst time had increased
levels of IL-12, TNF-α, IFN-γ, IL-13, CXCL1 and CCL2, while C57BL/6
mice only showed enhanced IL-12 production when compared to
mock-infected or re-infected mice (Fig. 6A–C). IL-12 production
was signiﬁcantly higher in BALB/c mice than in C57BL/6 mice after
primary infection (Fig. 6A). There was no signiﬁcant difference in
secretion of IL-12, TNF-α or IFN-γ after re-infection between the
strains. However, after re-infection C57BL/6 mice had higher levels
of IL-13, in comparison to BALB/c mice, while the IL-5 production
tended to be higher (Fig. 6B). Both strains showed increased IL-13
production after primary infection. We also found increased
secretion of CXCL1 and CCL2 in re-infected C57BL/6 mice com-
pared to BALB/c mice (Fig. 6C). Primary infection of elderly BALB/c
mice also resulted in inﬂux of pDCs into the lungs, but no
signiﬁcant increase in pDCs was observed in re-infected BALB/c
Fig. 2. Inﬂammatory response in neonatal BALB/c and C57BL/6 mice after primary
infection. Seven day-old BALB/c and C57BL/6 neonates were infected with 300 pfu
PVM-15 or received medium (Mock). Neonates were sacriﬁced on day 7 after PVM-
15 inoculation. Cytokines and chemokines were quantiﬁed in lung homogenates by
multiplex assay. Data are representative of two independent experiments with 5–8
mice per group and are presented as means 7 SEM. Signiﬁcance of differences is
shown as: nPo0.05; nnPo0.01; nnnPo0.001.
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mice (data not shown), and there was no inﬂux of pDCs in elderly
C57BL/6 mice after primary infection or re-infection.
Antibody responses in elderly BALB/c and C57BL/6 mice after primary
PVM infection and after re-infection
To determine whether elderly mice develop anamnestic
responses, neonatal BALB/c and C57BL/6 mice were infected with
PVM-15 and re-infected at 18 months of age. Antibody titers were
determined after primary infection and re-infection in both serum
and lungs. In contrast to the observations for neonatal mice, after
re-infection as elderly mice, BALB/c mice had higher serum IgG
titers in comparison to re-infected C57BL/6 mice (Fig. 7A). Inter-
estingly, the serum IgG levels were signiﬁcantly elevated in elderly
BALB/c mice after re-infection in comparison to their titers when
infected as neonates (Figs. 4 and 7A). There was no signiﬁcant
difference in lung IgG levels in re-infected mice between strains,
while BALB/c mice had higher IgA titers than C57BL/6 mice
(Fig. 7A). PVM-primed, re-infected elderly BALB/c and C57BL/6
mice both displayed a TH1/TH2 balanced immune response
(Fig. 7B). In contrast to what was observed for neonates, 18
month-old re-infected BALB/c mice had signiﬁcantly higher virus
neutralization antibody titers in lungs and serum compared to
C57BL/6 mice (Fig. 7C and D). These data show that BALB/c mice
developed an anamnestic response after re-infection at 18 months
of age, whereas C57BL/6 mice had a lower systemic antibody
response than after primary infection, not high enough to neu-
tralize the virus.
Lung pathology in elderly BALB/c and C57BL/6 mice after primary
infection or re-infection with PVM
In order to evaluate the degree of lung pathology induced in
BALB/c and C57BL/6 mice primed as neonates and re-infected as
Fig. 3. Plasmacytoid dendritic cell recruitment to lungs of neonatal BALB/c mice after primary infection. Seven day-old BALB/c and C57BL/6 mice were infected with 300 pfu
PVM-15 and an age-matched control group received medium (Mock). (A) A representation of pDC inﬂux in lungs (CD11cþ , mPDCA-1þ , CD45R/B220þ). (B) Plasmacytoid
dendritic cells in lungs of mock- and PVM-15 infected BALB/c and C57BL/6 mice. (C and D) Expression levels of IFN-α and IFN-β in BALB/c and C57BL/6 neonates calculated as
normalized fold-change over mock-infected mice euthanized on day 5 p.i. Data are representative of three independent experiments with 5 mice per group. Signiﬁcance of
differences is shown as: nPo0.05.
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elderly mice, lungs were evaluated by histology on day 6 after re-
infection in comparison to primary infection. The various degrees of
pathology are shown in Fig. 8A–D. There was a signiﬁcant difference
in lung score after primary infection and re-infection of 18 month-
old BALB/c mice. After primary infection, the 18 month-old BALB/c
mice had a score of 3 (Fig. 8E), which indicates perivasculitis,
alveolitis, interstitial edema, mononuclear cell inﬁltration near
alveolar spaces and blood vessels, multifocal hemorrhage, moderate
to locally extensive lesions. In contrast, re-infected BALB/c mice
primed as neonates showed inﬂux of mononuclear cells but no
perivasculitis, edema and alveolitis (Fig. 8E). The level of lung
pathology in BALB/c mice was in accordance with the weight loss,
disease symptoms and virus recovery observed in this study. C57BL/
6 mice developed perivasculitis and mild edema with inﬂux of
mononuclear cells with a score of 2 after both primary infection
and re-infection (Fig. 8E). The fact that re-infected and infected
C57BL/6 mice behaved in almost the same way based on the
histopathological scores is in agreement with the weight loss,
which did not differ in C57BL/6 mice after primary infection and
re-infection (Fig. 5A and B); furthermore, we recovered the same
amount of virus from lungs of 18 month-old C57BL/6 mice after
primary infection and after re-infection. Age-matched mice in the
control group of both strains did not show lung pathology (Fig. 8E).
These data conﬁrm that primary PVM infection as neonates
provides protection later in life in BALB/c but not in C57BL/6 mice.
Cell inﬂux into lungs of elderly C57BL/6 and BALB/c mice after
primary or re-infection with PVM
As cell inﬂux also plays an important part in PVM-induced
pathogenesis, we examined the lymphoid cell populations in the
lungs of elderly mice after primary infection or re-infection. There
was no signiﬁcant difference in the cell number in the lungs of
BALB/c mice after primary or re-infection (Fig. 9A), while re-
infected C57BL/6 mice had a higher number of cells in the lungs
than C57BL/6 mice infected for the ﬁrst time (Fig. 9A). Accordingly,
the total lung cell number was higher in C57BL/6 mice when
compared to BALB/c mice after re-infection (Fig. 9A). When
compared to primary infection, the CD4þ T cells numbers did
not signiﬁcantly decrease in BALB/c mice, but were lower in
C57BL/6 mice after re-infection (Fig. 9B) which agrees with the
lower antibody responses. As a result, the CD4þ T cell numbers
were higher in BALB/c mice than in C57BL/6 mice after re-
infection. In contrast the CD8þ T cell number was higher in re-
infected C57BL/6 mice than in C57BL/6 mice infected for the ﬁrst
time and re-infected BALB/c mice (Fig. 9B).
Discussion
The present study was performed to examine the innate and
adaptive immune responses in neonates after primary infection
with PVM-15 and after re-infection as elderly mice. The immune
response sequel after neonatal PVM infection and re-infection
depended upon the mouse strain. We observed a blunted inﬂam-
matory response in C57BL/6 neonates after PVM-15 infection
when compared to the response in BALB/c mice. Furthermore,
following re-infection as elderly mice, BALB/c mice primed as
neonates were protected from clinical disease when challenged
with a 10-fold higher dose than that used for primary infection,
while C57BL/6 mice did not develop protective immunity. The fact
that there was no evidence that the primed C57BL/6 mice were
protected from PVM challenge even when they do not develop
Fig. 4. Antibody responses in BALB/c and C57BL/6 mice after PVM infection as neonates. Seven day-old BALB/c and C57BL/6 neonates were infected with 300 pfu of PVM-15.
(A) PVM-speciﬁc serum IgG and lung IgA and IgG in BALB/c and C57BL/6 neonates 4 weeks after PVM-15 infection. (B) PVM-speciﬁc IgG1 and IgG2a (BALB/c) and IgG1 and
IgG2c (C57BL/6) in neonates 4 weeks after PVM infection. (C) Lung virus neutralization titers (50%) in PVM-infected BALB/c and C57BL/6 neonates. (D) Serum virus
neutralization titers (100%) in PVM-infected BALB/c and C57BL/6 neonates. Data are representative of two independent experiments with 6–8 mice per group and are
presented as means 7 SEM. Signiﬁcance of differences is shown as: nPo 0.05; nnPo 0.01; nnnPo 0.001.
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severe clinical disease after primary infection, further supports the
absence of protective immunity.
After infection with PVM-15 BALB/c neonates displayed
reduced weight gain from day 2 post-infection onwards, and
diverged signiﬁcantly from control neonates from day 4 to 7
post-infection. Enhanced secretion of pro-inﬂammatory cytokines
and chemokines with signiﬁcant inﬂux of pDCs into the lungs was
also observed. A similar response in BALB/c neonates was observed
previously with PVMJ336, where the authors emphasized the role
of TLR7-mediated signaling by pDCs in controlling pneumovirus
infection (Davidson et al., 2011). In fact, a study in adult C57BL/6
ChemR23- deﬁcient mice also suggested that recruitment of pDCs
and type 1 IFN production is required for pneumovirus clearance
(Bondue et al., 2011). Interestingly, in our study recruitment of
pDCs to the lungs and secretion of type 1 IFN in response to PVM
infection was only observed in BALB/c neonates and not in C57BL/
6 neonates. The lung inﬂammatory response in C57BL/6 neonates
was also signiﬁcantly lower, and the amount of weight loss on
days 6 and 7 post-infection was 20% lower than in BALB/c
neonates. Similarly, in another study neonatal C57BL/6 mice
infected with PVM J3666 at one week of age showed minimal
production of pro-inﬂammatory cytokines and chemokines, and
no signiﬁcant up-regulation of pDC recruitment (Bonville et al.,
2010). Previous studies have documented that inﬂammatory
responses after PVM infection in neonates differ from those in
adult mice, and that chemokines/cytokines associated with PVM
Fig. 5. Weight change and virus replication in lungs of 18 month-old BALB/c and
C57BL/6 mice after primary infection or re-infection. Seven day-old BALB/c and
C57BL/6 neonates were infected with 300 pfu PVM-15 (PI) and were re-infected at
18 months of age with 3000 pfu PVM-15 (RI). Two additional groups of 18 month-
old mice were infected with 3000 pfu PVM-15 or received medium (Mock). (A and
B) Mice were weighed daily up to day 6 p.i. Analysis of weight loss was performed
as a measure of disease severity, and change is expressed as % of original weight.
Data represent means 7 SEM. (C) Viral burden in lungs after primary infection as
neonates and subsequent -infection at 18 months of age (RI), as well as primary
infection at 18 months (PI). Virus titers are expressed as (log 10) pfu/g. Data are
representative of three independent experiments with 10–12 mice per group.
Signiﬁcance of differences is shown as: nPo 0.05; nnPo 0.01; nnnPo 0.001.
Fig. 6. Inﬂammatory response in 18 month-old BALB/c and C57BL/6 mice after
primary infection or re-infection. Seven day-old BALB/c and C57BL/6 neonates were
infected with 300 pfu PVM-15 (PI) and were re-infected at 18 months of age with
3000 pfu PVM-15 (RI). Control groups of 18 month-old mice received a primary
infection with 3000 pfu PVM-15 (PI) or medium (Mock). Mice were sacriﬁced on
day 6 p.i. Cytokines and chemokines were quantiﬁed in lung homogenates by
multiplex assay. Data are representative of two independent experiments with 5–8
mice per group and are presented as means 7 SEM. Signiﬁcance of differences is
shown as: nPo0.05; nnPo0.01; nnnPo0.001.
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pathogenesis are produced in an age-dependent manner (Bonville
et al., 2010). Our results are partially in agreement with this study
as C57BL/6 neonates infected with PVM-15 showed very limited
secretion of IL-12, TNF-α, IFN-γ CCL3, CCL2 and CXCL1, when
compared to BALB/c neonates. The limited secretion of IFN-γ in
C57BL/6 neonates parallels other studies in which authors using a
murine gammaherpes virus infection model showed that C57BL/6
mice did not require IFN-γ to control infection while BALB/c mice
did, and that robust chemokine expression in BALB/c mice did not
provide resistance to infection (Tsai et al., 2011; Weinberg et al.,
2004). Other well-documented studies also suggest that produc-
tion of IFN-γ, CCL3 and CCL11 is associated with acute and long-
term disease in RSV-challenged mice (Jafri et al., 2004). Further-
more, Bonville et al. (2004) showed that blockage of CCL3 or CCR1
in conjunction with speciﬁc antiviral therapy in PVM-infected
mice resulted in signiﬁcant reduction of morbidity and mortality.
Among the other possibilities that may address our ﬁndings is that
the failure to regulate pro-inﬂammatory cytokine and chemokine
secretion during the early phase of the innate immune response
leads to disease progression.
Studies with a neonatal mouse model indicate that primary
infection of BALB/c neonates with RSV strain A2 promotes a TH2-
biased immunopathology upon re-infection, and that a deﬁcit in
pDC response and type 1 interferon synthesis might be the reason
(Cormier et al., 2014b; You et al., 2013). In addition, the environ-
ment of the neonatal lung and the age at the time of primary
infection are major determinants in the outcome of reinfection
with RSV (Culley et al., 2002). In our study, however, BALB/c
neonates experienced inﬂux of pDCs, type I IFN expression and
disease after primary PVM infection, but were fully protected, with
a balanced TH1/TH2 response, after re-infection as elderly mice.
This was in contrast to C57BL/6 mice, which showed no pDC
inﬂux, little IFN up-regulation and less disease, but were not
protected later in life. These data suggest that as pneumoviruses
are highly species-speciﬁc, results obtained with human RSV in a
mouse model need to be interpreted with caution.
While BALB/c mice showed more disease than C57BL/6 mice
after primary infection as neonates, they were well protected from
re-infection as elderly; however, re-infected C57BL/6 mice experi-
enced the same level of weight loss, lung pathology, inﬂammation
and virus replication as mice with a primary infection. It has been
proposed that a skewed TH2 response and a limited ability of
neonates to generate an effective Th1 response results in compro-
mised immune responses against invading pathogens (Siegrist and
Aspinall, 2009). In addition, a weakened antibody response in
infancy undermines the vaccination efﬁcacy in neonates
(Tregoning et al., 2013). In the present study, serum IgG levels
after primary infection were higher in C57BL/6 neonates than in
BALB/c neonates, but interestingly, C57BL/6 mice did not develop
an increased serum IgG response upon re-infection, in contrast to
BALB/c mice which after re-infection showed enhanced IgG titers.
However, studies on inﬂuenza suggest that the level of protection
from re-infection can be best correlated with antibody levels in the
respiratory tract rather than in serum (Couch and Kasel, 1983; Ito
et al., 2003; Waffarn and Baumgarth, 2011). Therefore, it can be
argued that a higher serum IgG level in C57BL/6 neonates reﬂects
systemic immune responses and it is unclear to what extent this
can be directly linked to local immune responses in lungs, which
may contribute more to protection after re-infection. Local IgA
responses at mucosal surfaces are the ﬁrst line of defense upon re-
infection or infection after vaccination (van Riet et al., 2012). The
higher PVM-speciﬁc lung IgA levels in BALB/c neonates and re-
infected elderly mice, when compared to C57BL/6 mice, suggest
that generation of lung IgA in neonates after primary infection
may determine their susceptibility upon re-infection with PVM.
Furthermore, the difference in serum IgG between BALB/c and
Fig. 7. Antibody responses in BALB/c and C57BL/6 mice after PVM infection as neonates and re-infection as elderly. Seven day-old BALB/c and C57BL/6 neonates were
infected with 300 pfu, and re-infected with 3000 pfu PVM-15 at 18 months of age. (A) PVM-speciﬁc serum IgG and lung IgA and IgG in 18 month-old BALB/c and C57BL/6
mice primed as neonates and quantiﬁed 6 days after PVM-15 re-infection. (B) PVM-speciﬁc IgG1 and IgG2a or IgG2c in 18 month-old BALB/c and C57BL/6 mice primed as
neonates on day 6 after re-infection. (C) Lung virus neutralization titers (50%) in re-infected 18 month-old BALB/c and C57BL/6 mice. (D) Serum virus neutralization titers
(100%) in re-infected 18 month-old BALB/c and C57BL/6 mice. Data are representative of two independent experiments with 6–8 mice per group and are presented as means
7 SEM. Signiﬁcance of differences is shown as: nPo 0.05; nnPo 0.01; nnnPo 0.001.
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C57BL/6 mice after re-infection might indicate that a transudate
from the serum to the lung may also have contributed to the
higher systemic and local virus neutralizing titers and protection
in re-infected BALB/c mice.
Recently, Tregoning et al. (2013) observed that RSV infection in
BALB/c neonates generates a relatively weak antibody response and
that blocking of IFN-γ can signiﬁcantly augment this. In contrast, in
context of PVM-15 infection in BALB/c neonates we observed an
increase in a number of cytokines including IFN-γ after primary
infection and a strong virus neutralizing antibody response, as well
as signiﬁcant protection, upon re-infection. However, this paradox
can again be explained by the fact that although PVM and RSV have
numerous striking similarities, they are two different viruses, natu-
rally infecting different species. The increased cell numbers in the
lungs of re-infected elderly C57BL/6 mice when compared to BALB/c
mice occurred likely in response to the higher viral load and is also
correlated to the increased numbers of CD8þ T cells which are
required for viral clearance. The CD4þ T cells, however, were lower in
re-infected C57BL/6 mice, which are correlated to the reduced virus
neutralizing antibody response after re-infection.
When BALB/c mice were infected with PVM, the innate immune
response generated in the lungs to overcome viral replication/attack
was insufﬁcient, which in turn created an imbalanced wave of pro-
inﬂammatory responses (inﬂammatory cytokines and chemokines)
leading to tissue damage thus contributing to immunopathology.
Furthermore, our previous results in adult mice showed that the
serum IgG response as a measure of the systemic immune response
was slightly higher in C57BL/6 mice on day 14 and was maintained
up to day 28, while the development of serum IgG responses in
BALB/c mice was slower reaching the same level as that in C57BL/6
mice on day 28 (Watkiss et al., 2013). In neonates the serum IgG
response to PVM-15 after primary infection was also signiﬁcantly
higher in C57Bl/6 mice. However, the mucosal IgA levels were higher
in BALB/c mice. We speculate that the enhanced pro-inﬂammatory
response and slow development of adaptive responses in BALB/c
mice causes more disease after primary infection with PVM-15.
Fig. 8. Lung pathology in 18 month-old BALB/c and C57BL/6 mice after primary infection or re-infection with PVM-15. Seven day-old BALB/c and C57BL/6 neonates were
infected with 300 pfu PVM-15 (PI) and re-infected at 18 months of age with 3000 pfu PVM-15 (RI). A control group of 18 month-old mice were given a primary infection with
3000 pfu PVM-15 (PI) and another group of 18 month-old mice received medium (Mock). Three mice per group were sacriﬁced on day 6 post-infection for histopathological
analysis. The mean histopathological scores in lungs were determined based on the following parameters: (i) alveolitis (ii) perivasculitis (iii) edema (iv) mononuclear cell
inﬁltration. (A) normal lung morphology of 18 month-old mice (B) representative lung section for animals scoring 1 (C) representative lung section for animals scoring 2
(D) representative lung section for animals scoring 3. (E) Histology scores shown as means 7 SEM for all groups. Signiﬁcance of differences is shown as: nPo0.05.
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Nevertheless, the ultimate adaptive immune response is robust and
perfectly effective in generating a proﬁcient memory response after
re-infection resulting in high systemic and local virus neutralizing
antibodies and protection.
In conclusion, our study suggests that induction of an innate
pro-inﬂammatory response and IgA in the lungs of BALB/c mice
during neonatal primary infection with PVM contributes towards
protection after re-infection as elderly mice. Furthermore, in
addition to MHC, we speculate that other genes also contribute
in regulating susceptibility of primed mice to re-infection with
PVM-15.
Materials and methods
Cell lines, animals and PVM inoculation
Baby Hamster Kidney (BHK)-21 cells were grown in medium
consisting of Dulbecco's Modiﬁed Eagle Medium (DMEM; Sigma-
Aldrich, St. Louis, MO, USA) supplemented with 2% fetal bovine
serum (FBS, PAA Laboratories Inc., Etobicoke, ON, Canada), 0.1 mM
non-essential amino acids (Invitrogen/Life Technologies, Carlsbad,
CA, USA), 10 mM HEPES (Invitrogen), and 50 μg/ml gentamicin
(Invitrogen/Life Technologies). PVM-15 was propagated in BHK-21
cells as previously described (Watkiss et al., 2013). To propagate PVM
15, BHK cells were grown to 80% conﬂuency. Subsequently, the
medium was removed, the cells were washed gently, and the
medium was replaced with 14.5 ml of medium and 1.5 ml of PVM
(106 pfu, equivalent to an MOI of 0.01–0.1) per ﬂask, and the cells
were incubated at 37 1C, 5% CO2. After 72 h, the virus was harvested
by scraping cells into the supernatant with a 15 mm cell scraper
(Corning Inc., NY, USA); the cell debris was disrupted as much as
possible by pipetting up and down. This mixture was used as viral
stock to infect additional ﬂasks of BHK cells, and aliquots were stored
at 80 1C. For assays requiring PVM-infected and mock-infected cell
lysates, an equal number of ﬂasks were inoculated with 16 ml of
medium alone. BHK21 cells cultured without PVM-15 were used as
control in each experiment. Pregnant mice were obtained at 14 days
of gestation (Charles River Laboratories, Wilmington, DE, USA). BALB/
c and C57BL/6 pups born on the same date were inoculated
intranasally with 300 pfu PVM-15 on day 7 of age. Control pups
received BHK21 cell lysate in medium without PVM-15 (Mock). Mice
were not anesthetized before virus inoculation. Six pups per group
were euthanized on days 3, 5 and 7 to collect lungs. At 18 months of
age (78 weeks) the remaining mice were re-infected by intranasal
inoculation of 3000 pfu PVM-15. Age-matched mice received a
primary infection with an equivalent amount of PVM-15 or were
mock-infected with BHK21 cells lysate in medium without PVM-15.
Mice were weighed daily and scored for clinical illness to monitor
disease severity according to a modiﬁed version of Morton and
Grifﬁths (1985). Ten to twelve mice/group were euthanized on day
7 after primary infection and day 6 after re-infection with PVM-15 to
collect the lungs. Mice were bled out by cardiac puncture. All animal
studies were performed according to the guidelines of the Canadian
Council for Animal Care.
Collection of lung samples
Lung samples were collected as described previously (Watkiss
et al., 2013). Brieﬂy, the single-lobed, left lung was clamped off and
used for histology. A part of the multi-lobed, right lung was
collected into Trizols reagent (Invitrogen/Life Technologies) for
RNA isolation and the other part into tissue culture medium for
preparation of lung homogenates. All samples were ﬂash-frozen in
liquid nitrogen immediately following centrifugation, and stored
at 80 1C.
Cell isolation and ﬂow cytometry
Cell isolation from lungs was carried out as previously des-
cribed (Watkiss et al., 2013). Perfused lungs were processed to
make a single cell suspension. Cell viability was assessed by trypan
blue exclusion. Total cell numbers were counted using a Beckman
coulter counter. Cell staining was performed as previously des-
cribed (Watkiss et al., 2013). For surface staining, the following
antibodies were used: anti-CD3 (cat no.555275), anti-CD4 (cat
no.553729), anti-CD8 (cat no.553031), anti-CD11c (cat no. 117308),
anti CD45R/B220 (cat no.103205) (BioLegend, San Diego, CA, USA)
and m-PDCA-1 (5120327174) (Miltenyi Biotec, Bergisch Gladbach,
Germany). To detect pDCS, cells were ﬁrst gated on CD11c and
then the expression of m-PDCA-1 and CD45R./B220 was checked.
PDCs were reported as CD11cþ , m-PDCA1þ and CD45R/B220þ .
Cells were gated for live cells, singlets and lymphocytes and then
analyzed. Flow cytometry was performed using a FACS Calibur (BD
Fig. 9. Cell recruitment to lungs of BALB/c and C57BL/6 mice after primary infection or re-infection at 18 months of age. Seven day-old BALB/c and C57BL/6 mice were
infected with 300 pfu PVM-15, and they were re-infected at 18 months of age with 3000 pfu PVM- 15 (RI). Two other groups of 18 month-old mice received a primary
infection with 3000 pfu PVM-15 (PI) or medium (Mock). (A) Total cell numbers in the lungs. (B) The percentage of CD3þ/CD4þ and CD3þ/CD8þ T cells in the lungs. Data are
representative of three independent experiments with 5 mice per group and are presented as means 7 SEM. Signiﬁcance of differences is shown as: nPo0.05; nnPo0.01;
nnnPo0.001.
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Biosciences, San Jose, CA, USA). Analysis of ﬂow cytometry data
was performed using Kaluza software (Beckman Coulter, Brea,
CA, USA).
Cytokine multiplex assay
An electrochemiluminescence (ECL) detection-based meso
scale discovery (MSD) multiplex platform and Sector Imager
2400 (MSD, Gaithersburg, MD, USA) were used to quantify
cytokines and chemokines in cell-free supernatants of lung homo-
genates. The assay was performed according to the manufacturer's
instructions. The MSD Discovery Workbench Software was used to
analyze the results.
PVM quantiﬁcation
PVM was quantiﬁed using a standard immunoﬂuorescent
plaque assay as previously described (Watkiss et al., 2013). Brieﬂy,
tenfold serial dilutions of lung homogenates were made and
transferred in duplicate onto 80% conﬂuent BHK-21 cell mono-
layers. After incubation for 72 h at 37 1C, cells were ﬁxed with an
ice-cold solution of (4:1) acetone and methanol, and dried at room
temperature. Plates were blocked for 30 min in PBS containing 5%
goat serum (Invitrogen), followed by a 2–3 h incubation with a
1:500 dilution of a PVM N protein-speciﬁc polyclonal rabbit
antibody (made in-house) in PBS containing 1% goat serum.
Subsequently, the plates were washed and incubated in the dark
with an Alexaﬂuor488-conjugated goat anti-rabbit antibody (Life
Technologies). Plaques were counted using a ﬂuorescence micro-
scope (Zeiss, Jena, Germany). The titers were expressed as PFU per
gram lung tissue.
Enzyme-linked immunosorbent assay and lung fragment cultures
Lung fragment cultures (LFC) were prepared by incubating
minced lung pieces 1 mm in diameter in LFC medium (RPMI
1540 medium supplemented with 0.1 mM non-essential amino
acids, 10 mM HEPES buffer, 1 mM sodium pyruvate, 2 mM L-glu-
tamine, antibiotic/antimycotic, 50 μg/mL gentamicin) (Invitrogen/
Life Technologies), for ﬁve days at 37 1C. Subsequently, culture
media were centrifuged, and the supernatants were stored at
80 1C. PVM-speciﬁc IgG and IgA were evaluated in LFC by ELISA
as described previously (Watkiss et al., 2013). PVM-speciﬁc IgA,
IgG, IgG1, IgG2a and IgG2c were evaluated in serum. Brieﬂy, 96-
well microtitre plates were coated with PVM-positive or negative
antigen and dried overnight. Coated plates were washed, and four-
fold serially diluted serum samples were added and incubated
overnight at 4 1C. The next day plates were washed and alkaline
phosphatase (AP)-conjugated goat anti-mouse IgG (Kirkegaard &
Perry Laboratories, Gaithersburg, MD, USA), or biotin-labelled goat
anti-mouse IgG1, IgG2a and IgG2c (Southern Biotech, Birmingham,
AL, USA) or IgA (Invitrogen/Life Technologies) were added, and
plates were incubated at room temperature (RT) for 1–2 h. For IgA,
IgG1, IgG2a and IgG2c an additional 1 h incubation with alkaline
phosphatase-conjugated streptavidin (Jackson ImmunoResearch
Laboratories, Baltimore, MD, USA) was carried out at RT. Plates
were developed with p-nitrophenyl phosphate (Sigma-Aldrich, St
Louis, MO, USA) and read at 450 nm with a reference wavelength
of 490 nm.
Neutralization assay
PVM-speciﬁc neutralization titers were assayed as previously
described (Watkiss et al., 2013). Brieﬂy LFC supernatants and sera
were serially diluted and an equal volume of PVM-15 at a
concentration of 500 pfu/well was added and incubated at 37 1C
for 1 h. Subsequently, the virus mixture was transferred in
duplicate onto 80% conﬂuent BHK-21 cell monolayers. After
incubation for 72 h at 37 1C, cells were ﬁxed with an ice-cold
solution of (4:1) acetone and methanol, and dried at RT. Plates
were blocked for 30 min in PBS containing 5% goat serum
(Invitrogen), followed by 2–3 h incubation with a 1:500 dilution
of a PVM N protein-speciﬁc polyclonal rabbit antibody (made in-
house) in PBS containing 1% goat serum. After the incubation
plates were washed and incubated in the dark with an
Alexaﬂuor488-conjugated goat anti-rabbit antibody. Plaques were
counted using a ﬂuorescent microscope (Zeiss).
Lung histology
On day 6 post-infection the multi-lobed right lung was per-
fused with 1 ml of 10% neutral buffered formalin (VWR, Radnor,
PA, USA) and immersed in formalin after being placed in a
cassette. The perfused lungs were then processed as described
previously (Watkiss et al., 2013) and scored in a blinded manner.
Scores were given based on the presence and severity, as well as
the dissemination of lesions characterized by cellular inﬁltrates
and edema in the tissue surrounding the bronchioles and blood
vessels visible in lung sections. A score of 0 denotes a normal lung,
1 indicates signs of perivascular edema and mild perivasculitis,
limited to small foci that were not widespread, while a score of
2 denotes moderate levels of perivasculitis, vasculitis, and multi-
focal perivascular edema. Finally, a score of 3 represents animals
with extensive, severe, multifocal perivasculitis, vasculitis, and
vascular edema, and/or necrosis with ﬁbrin and cell debris.
Analysis of type-1 IFN mRNA expression
RNA isolation was performed according to the manufacturer's
instructions (Invitrogen, Life Technologies). cDNA synthesis was
carried out with a QuantiTect Reverse Transcription Kit (Qiagen,
Venlo, Netherlands) and real-time PCR (qPCR) was carried out
using FastStart SYBR Green Master (Roche, Basel, Switzerland)
according to the manufacturer's instructions. The primers and
annealing temperatures used in the qPCR experiments are as
follows: IFN-α (Forward primer: CCTGTGTGATGCAACAGGTC; Re-
verse primer: TCACTCCTCCTTGCTCAATC; annealing temperature:
59.3 1C), and IFN-β (Forward primer: ATCATGAACAACAGGTG-
GATCCTCC; Reverse primer: TTCAAGTGGA GAGCAGTTGAG; an-
nealing temperature 63.9 1C). The qPCR reaction was carried out
according to the following parameters: 40 cycles of denaturation
at 95 1C for 15 s, followed by 30 s of annealing and extension. The
samples were normalized against β-actin and expressed as the
normalized fold-change over mock-infected control animals
euthanized on the same day.
Statistical analysis
Statistical software (Graph Pad Prism Version 6.00) was used to
analyze all data. One-way ANOVA with Newman–Keuls post-test
was used to compare differences between multiple groups. If a
signiﬁcant difference was found, pairs of groups were compared
using the Mann–Whitney U test. Differences were considered
signiﬁcant if Po0.05.
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